GNMX Latest Press Releases, Aevi Genomic Med Corporate News

Releases

0.1659

0.00%

0.00

All
Financials
Insiders

4 Aevi Genomic Medicine, LLC (0001138776) (Issuer)
Jun 11,2020 20:15
SC 13G/A Aevi Genomic Medicine, LLC (0001138776) (Subject)
Feb 14,2020 16:14
EFFECT Aevi Genomic Medicine, LLC (0001138776) (Filer)
Feb 14,2020 00:15
EFFECT Aevi Genomic Medicine, LLC (0001138776) (Filer)
Feb 14,2020 00:15
EFFECT Aevi Genomic Medicine, LLC (0001138776) (Filer)
Feb 14,2020 00:15
SC 13G/A Aevi Genomic Medicine, LLC (0001138776) (Subject)
Feb 12,2020 16:28
S-8 POS Aevi Genomic Medicine, LLC (0001138776) (Filer)
Feb 12,2020 15:49
S-8 POS Aevi Genomic Medicine, LLC (0001138776) (Filer)
Feb 12,2020 15:48
S-8 POS Aevi Genomic Medicine, LLC (0001138776) (Filer)
Feb 12,2020 15:47
S-8 POS Aevi Genomic Medicine, LLC (0001138776) (Filer)
Feb 12,2020 15:46
S-8 POS Aevi Genomic Medicine, LLC (0001138776) (Filer)
Feb 12,2020 15:45
S-8 POS Aevi Genomic Medicine, LLC (0001138776) (Filer)
Feb 12,2020 15:44
S-8 POS Aevi Genomic Medicine, LLC (0001138776) (Filer)
Feb 12,2020 15:42
POS AM Aevi Genomic Medicine, LLC (0001138776) (Filer)
Feb 12,2020 15:41
POS AM Aevi Genomic Medicine, LLC (0001138776) (Filer)
Feb 12,2020 15:41
POS AM Aevi Genomic Medicine, LLC (0001138776) (Filer)
Feb 12,2020 15:40
4 Aevi Genomic Medicine, Inc. (0001138776) (Issuer)
Feb 07,2020 12:58
3 Aevi Genomic Medicine, Inc. (0001138776) (Issuer)
Feb 07,2020 12:57
SC 13D Aevi Genomic Medicine, Inc. (0001138776) (Subject)
Feb 07,2020 12:56
4 Aevi Genomic Medicine, Inc. (0001138776) (Issuer)
Feb 05,2020 16:25
4 Aevi Genomic Medicine, Inc. (0001138776) (Issuer)
Feb 05,2020 16:24
Form4 Aevi Genomic Medicine, Inc.
Feb 05,2020 16:23
4 Aevi Genomic Medicine, Inc. (0001138776) (Issuer)
Feb 05,2020 16:21
4 Aevi Genomic Medicine, Inc. (0001138776) (Issuer)
Feb 05,2020 16:20
4 Aevi Genomic Medicine, Inc. (0001138776) (Issuer)
Feb 05,2020 16:18
4 Aevi Genomic Medicine, Inc. (0001138776) (Issuer)
Feb 05,2020 16:16
4 Aevi Genomic Medicine, Inc. (0001138776) (Issuer)
Feb 05,2020 16:15
4 Aevi Genomic Medicine, Inc. (0001138776) (Issuer)
Feb 05,2020 16:13
4 Aevi Genomic Medicine, Inc. (0001138776) (Issuer)
Feb 05,2020 16:11
Form25-NSE Aevi Genomic Medicine, Inc.
Feb 03,2020 16:32
8-K Aevi Genomic Medicine, Inc. (0001138776) (Filer)
Feb 03,2020 16:30
SC 13D/A Aevi Genomic Medicine, Inc. (0001138776) (Subject)
Jan 06,2020 16:06
DEFM14A Aevi Genomic Medicine, Inc. (0001138776) (Filer)
Dec 31,2019 16:46
8-K Aevi Genomic Medicine, Inc. (0001138776) (Filer)
Dec 23,2019 07:32
425 Aevi Genomic Medicine, Inc. (0001138776) (Subject)
Dec 23,2019 07:31
425 Aevi Genomic Medicine, Inc. (0001138776) (Subject)
Dec 23,2019 07:30
425 Aevi Genomic Medicine, Inc. (0001138776) (Subject)
Dec 10,2019 21:36
425 Aevi Genomic Medicine, Inc. (0001138776) (Subject)
Dec 10,2019 21:31
4 Aevi Genomic Medicine, Inc. (0001138776) (Issuer)
Dec 09,2019 21:15
4 Aevi Genomic Medicine, Inc. (0001138776) (Issuer)
Dec 09,2019 21:12
4 Aevi Genomic Medicine, Inc. (0001138776) (Issuer)
Dec 09,2019 21:10
8-K Aevi Genomic Medicine, Inc.
Dec 09,2019 20:39
425 Aevi Genomic Medicine, Inc. (0001138776) (Subject)
Dec 09,2019 20:38
SC 13D/A Aevi Genomic Medicine, Inc. (0001138776) (Subject)
Dec 06,2019 17:18
8-K Aevi Genomic Medicine, Inc. (0001138776) (Filer)
Dec 05,2019 16:15
425 Aevi Genomic Medicine, Inc. (0001138776) (Subject)
Dec 05,2019 16:13
8-K Aevi Genomic Medicine, Inc. (0001138776) (Filer)
Nov 22,2019 16:05
SC 13D/A Aevi Genomic Medicine, Inc. (0001138776) (Subject)
Nov 20,2019 16:30
8-K Aevi Genomic Medicine, Inc. (0001138776) (Filer)
Nov 20,2019 16:06
10-Q Aevi Genomic Medicine, Inc. (0001138776) (Filer)
Nov 14,2019 08:01

Webull provides the latest Aevi Genomic Med (GNMX) stock and general news. This information may help you make smarter investment decisions.

About GNMX

Aevi Genomic Medicine, Inc., formerly Medgenics, Inc., is focused on genomic medicine. The Company is engaged in unlocking the potential of genomic medicine to translate genetic discoveries into therapies. The Company is engaged in developing therapies for children and adults with pediatric onset life altering diseases. The Company's product candidates include AEVI-001 and AEVI-002. The Company's research and development efforts leverage an internal genomics platform and a collaboration with the Center for Applied Genomics (CAG) at The Children's Hospital of Philadelphia (CHOP). .